TAMPA, Fla.--(BUSINESS WIRE)--Aug. 10, 2006--Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) (“Nanobac” or “the Company”) today announced the publication by independent researchers of a proof of concept that calcifying nanoparticles, also known as nanobacteria, promote disease.
